TYJAKTO Trademark

Trademark Overview


On Friday, November 6, 2020, a trademark application was filed for TYJAKTO with the United States Patent and Trademark Office. The USPTO has given the TYJAKTO trademark a serial number of 90302777. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, May 11, 2022. This trademark is owned by Pfizer Inc.. The TYJAKTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for the treatment of atopic dermatitis, eczema, psoriasis, lupus, inflammatory bowel disease, crohn's disease, ulcerative colitis, psoriatic arthritis, alopecia areata, vitiligo, and hidradenitis suppurativa
tyjakto

General Information


Serial Number90302777
Word MarkTYJAKTO
Filing DateFriday, November 6, 2020
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, May 11, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for the treatment of atopic dermatitis, eczema, psoriasis, lupus, inflammatory bowel disease, crohn's disease, ulcerative colitis, psoriatic arthritis, alopecia areata, vitiligo, and hidradenitis suppurativa

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, May 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Wednesday, May 11, 2022ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Wednesday, May 11, 2022ABANDONMENT - AFTER PUBLICATION
Tuesday, May 10, 2022TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, November 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 15, 2021SOU EXTENSION 1 GRANTED
Monday, November 15, 2021SOU EXTENSION 1 FILED
Monday, November 15, 2021TEAS EXTENSION RECEIVED
Tuesday, June 1, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 6, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 26, 2021ASSIGNED TO EXAMINER
Friday, January 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 10, 2020NEW APPLICATION ENTERED IN TRAM